Gaetane C. Michaud, MD Chief of Interventional Pulmonary Medicine, NYU Langone Health, New York, New York
Join Dr. Michaud as she uses a case-based approach to highlight clinical factors to consider when selecting a lung cancer diagnostic tool to facilitate biomarker-driven clinical decision making in advanced non-small cell lung cancer (NSCLC), and reviews some best practices for optimizing biomarker testing.
Case Study Patient Case: Biomarker Testing in Advanced NSCLC
Chung-Che (Jeff) Chang, MD, PhD A Case-Based Pathology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD A Case-Based Oncology Perspective on Biomarker Testing in NSCLC
Chung-Chee (Jeff) Chang, MD, PhD A Pathology Perspective on Biomarker Testing in NSCLC
Martin Dietrich, MD, PhD A Community Oncology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD A Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD An Oncology Perspective on Biomarker Testing in NSCLC
